Active Ingredient
(in each caplet)
Meclizine HCl 12.5 mg USP
The following Structured Product Label (SPL) was submitted to the FDA by Blenheim Pharmacal, Inc. for the product Meclizine Hcl (NDC 10544-249). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, directions, other information, inactive ingredients, questions or comments, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each caplet)
Meclizine HCl 12.5 mg USP
Antiemetic
prevents and treats nausea, vomiting, or dizziness due to motion sickness
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
When using this product
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid
Call 1-800-645-2158, 9 am – 5 pm ET, Monday - Friday
TAMPER EVIDENT: DO NOT USE IF CARTON IS OPENED OR BLISTER UNIT IS BROKEN OR DAMAGED
Rugby® Duluth, Georgia 30097
Meclizine HCl Caplets, USP 12.5mg
6 Caplets
NDC 10544-249-06
* Please review the disclaimer below.